Kindly MD (NASDAQ: NAKA) moves to delist its NAKAW tradeable warrants
Rhea-AI Filing Summary
Kindly MD, Inc. filed a Form 25 to remove its tradeable warrants to purchase shares of common stock (Nasdaq: NAKAW) from listing on The Nasdaq Stock Market LLC. This action relates specifically to the warrant class, not the underlying common stock, and is a formal step in ending exchange trading and/or registration of these warrants under Section 12(b) of the Securities Exchange Act of 1934.
Positive
- None.
Negative
- None.
Insights
Kindly MD is delisting its Nasdaq-listed warrants, affecting liquidity and trading access for that specific security.
Kindly MD, Inc. has submitted a Form 25 to remove its tradeable warrants (Nasdaq: NAKAW) from listing on The Nasdaq Stock Market LLC under Section 12(b) of the Exchange Act. Form 25 is the standard mechanism U.S. issuers use to delist or deregister a class of securities from a national exchange.
This filing applies to the warrants rather than the common stock itself, so the direct impact is concentrated on holders of that warrant class. Once the process is complete, these warrants typically cease trading on Nasdaq, which can reduce liquidity and may shift any remaining trading, if available, to less liquid venues.
The filing is signed by the company’s Chief Executive Officer, David Bailey, dated August 15, 2025, confirming that the issuer believes it meets the requirements for this delisting action. Subsequent disclosures in future company filings may provide further context on the status of the underlying common shares and any alternative trading arrangements, if applicable.